Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. Reply. The New England journal of medicine Egbuna, O., Chertow, G. M. 2023; 388 (26): 2491

View details for DOI 10.1056/NEJMc2304780

View details for PubMedID 37379148